299 related articles for article (PubMed ID: 31665429)
1. DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy.
Liu H; Zhang W; Zou B; Wang J; Deng Y; Deng L
Nucleic Acids Res; 2020 Jan; 48(D1):D871-D881. PubMed ID: 31665429
[TBL] [Abstract][Full Text] [Related]
2. An integrated framework for identification of effective and synergistic anti-cancer drug combinations.
Sharma A; Rani R
J Bioinform Comput Biol; 2018 Oct; 16(5):1850017. PubMed ID: 30304987
[TBL] [Abstract][Full Text] [Related]
3. In silico drug combination discovery for personalized cancer therapy.
Jeon M; Kim S; Park S; Lee H; Kang J
BMC Syst Biol; 2018 Mar; 12(Suppl 2):16. PubMed ID: 29560824
[TBL] [Abstract][Full Text] [Related]
4. DrugComb: an integrative cancer drug combination data portal.
Zagidullin B; Aldahdooh J; Zheng S; Wang W; Wang Y; Saad J; Malyutina A; Jafari M; Tanoli Z; Pessia A; Tang J
Nucleic Acids Res; 2019 Jul; 47(W1):W43-W51. PubMed ID: 31066443
[TBL] [Abstract][Full Text] [Related]
5. Methods for High-throughput Drug Combination Screening and Synergy Scoring.
He L; Kulesskiy E; Saarela J; Turunen L; Wennerberg K; Aittokallio T; Tang J
Methods Mol Biol; 2018; 1711():351-398. PubMed ID: 29344898
[TBL] [Abstract][Full Text] [Related]
6. HANSynergy: Heterogeneous Graph Attention Network for Drug Synergy Prediction.
Cheng N; Wang L; Liu Y; Song B; Ding C
J Chem Inf Model; 2024 May; 64(10):4334-4347. PubMed ID: 38709204
[TBL] [Abstract][Full Text] [Related]
7. Statistical assessment and visualization of synergies for large-scale sparse drug combination datasets.
Amzallag A; Ramaswamy S; Benes CH
BMC Bioinformatics; 2019 Feb; 20(1):83. PubMed ID: 30777010
[TBL] [Abstract][Full Text] [Related]
8. SNSynergy: Similarity network-based machine learning framework for synergy prediction towards new cell lines and new anticancer drug combinations.
Huangfu X; Zhang C; Li H; Li S; Li Y
Comput Biol Chem; 2024 Jun; 110():108054. PubMed ID: 38522389
[TBL] [Abstract][Full Text] [Related]
9. Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles.
Li X; Xu Y; Cui H; Huang T; Wang D; Lian B; Li W; Qin G; Chen L; Xie L
Artif Intell Med; 2017 Nov; 83():35-43. PubMed ID: 28583437
[TBL] [Abstract][Full Text] [Related]
10. Network Propagation Predicts Drug Synergy in Cancers.
Li H; Li T; Quang D; Guan Y
Cancer Res; 2018 Sep; 78(18):5446-5457. PubMed ID: 30054332
[TBL] [Abstract][Full Text] [Related]
11. H-RACS: a handy tool to rank anti-cancer synergistic drugs.
Yan X; Yang Y; Chen Z; Yin Z; Deng Z; Qiu T; Tang K; Cao Z
Aging (Albany NY); 2020 Nov; 12(21):21504-21517. PubMed ID: 33173014
[TBL] [Abstract][Full Text] [Related]
12. Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment.
Friedman AA; Amzallag A; Pruteanu-Malinici I; Baniya S; Cooper ZA; Piris A; Hargreaves L; Igras V; Frederick DT; Lawrence DP; Haber DA; Flaherty KT; Wargo JA; Ramaswamy S; Benes CH; Fisher DE
PLoS One; 2015; 10(10):e0140310. PubMed ID: 26461489
[TBL] [Abstract][Full Text] [Related]
13. CDCDB: A large and continuously updated drug combination database.
Shtar G; Azulay L; Nizri O; Rokach L; Shapira B
Sci Data; 2022 Jun; 9(1):263. PubMed ID: 35654801
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models.
Zhang T; Zhang L; Payne PRO; Li F
Methods Mol Biol; 2021; 2194():223-238. PubMed ID: 32926369
[TBL] [Abstract][Full Text] [Related]
15. Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors.
OcaƱa A; Freedman O; Amir E; Seruga B; Pandiella A
Cancer Metastasis Rev; 2014 Mar; 33(1):295-307. PubMed ID: 24338003
[TBL] [Abstract][Full Text] [Related]
16. Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer.
Malyutina A; Majumder MM; Wang W; Pessia A; Heckman CA; Tang J
PLoS Comput Biol; 2019 May; 15(5):e1006752. PubMed ID: 31107860
[TBL] [Abstract][Full Text] [Related]
17. Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs.
Abd El-Hafeez T; Shams MY; Elshaier YAMM; Farghaly HM; Hassanien AE
Sci Rep; 2024 Jan; 14(1):2428. PubMed ID: 38287066
[TBL] [Abstract][Full Text] [Related]
18. Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen.
Menden MP; Wang D; Mason MJ; Szalai B; Bulusu KC; Guan Y; Yu T; Kang J; Jeon M; Wolfinger R; Nguyen T; Zaslavskiy M; ; Jang IS; Ghazoui Z; Ahsen ME; Vogel R; Neto EC; Norman T; Tang EKY; Garnett MJ; Veroli GYD; Fawell S; Stolovitzky G; Guinney J; Dry JR; Saez-Rodriguez J
Nat Commun; 2019 Jun; 10(1):2674. PubMed ID: 31209238
[TBL] [Abstract][Full Text] [Related]
19. A novel approach to predicting the synergy of anti-cancer drug combinations using document-based feature extraction.
Shim Y; Lee M; Kim PJ; Kim HG
BMC Bioinformatics; 2022 May; 23(1):163. PubMed ID: 35513784
[TBL] [Abstract][Full Text] [Related]
20. Multi-way relation-enhanced hypergraph representation learning for anti-cancer drug synergy prediction.
Liu X; Song C; Liu S; Li M; Zhou X; Zhang W
Bioinformatics; 2022 Oct; 38(20):4782-4789. PubMed ID: 36000898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]